RxDoctor Payments Data

Laura Neilsen, PA

Medical · Aurora, ILNPI 1285886721

Payments from drug & device makers

$1,241in general payments, 2019–2025

Across 55 payments — averaging $22.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$271
  • Daiichi Sankyo Inc.$150
  • Genentech USA, Inc.$149
  • Lilly USA, LLC$135
  • Pfizer$104
  • Gilead$73
  • plus $359 from 11 others

What the payments were for

  • Food & beverage$1,22098%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,241 in reported general payments places this provider in the 70th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois

Medicare billing

Part B allowed, 2024
$49,906
Medicare patients
452
Services billed
1,783

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate23$419,499
Lenalidomide19$324,856
Abiraterone Acetate89$251,114
IbrancePalbociclib16$246,099
RevlimidLenalidomide16$226,875
BrukinsaZanubrutinib15$214,840
LynparzaOlaparib12$202,442
XareltoRivaroxaban66$91,713
EliquisApixaban104$85,118
Imatinib Mesylate30$62,441
VenclextaVenetoclax12$32,671
Anastrozole180$2,978
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen76$2,415
Exemestane12$1,914
ValacyclovirValacyclovir Hcl20$1,897

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationJakafi$33$419,49923 claims
PfizerIbrance, Eliquis$104$331,217120 claims
Bristol Myers SquibbRevlimid$27$226,87516 claims
AstraZenecaLynparza$50$202,44212 claims
Johnson & JohnsonXarelto$18$91,71366 claims
AbbVieVenclexta$27$32,67112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 449 medical providers in Illinois.

Other medical in Aurora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →